JOHNSON & JOHNSON Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHNSON & JOHNSON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHNSON & JOHNSON. JOHNSON & JOHNSON is a 10% Owner in JOHNSON & JOHNSON ($JNJ) and a 10% Owner in BARRIER THERAPEUTICS INC ($BTRX) and a 10% Owner in CORNERSTONE THERAPEUTICS INC ($CRTX) and a 10% Owner in IMMUNICON CORP ($IMMC) and a 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and a 10% Owner in TENGION INC ($TNGN) and a 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and a 10% Owner in Protagonist Therapeutics, Inc ($PTGX) and a 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a 10% Owner in NEVRO CORP ($NVRO) and a 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and a 10% Owner in Minerva Neurosciences, Inc. ($NERV) and a 10% Owner in Inspire Medical Systems, Inc. ($INSP) and a 10% Owner in Provention Bio, Inc. ($PRVB) and a 10% Owner in Fusion Pharmaceuticals Inc. ($FUSN).

Address: ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK 08933 NJ

Companies in which JOHNSON & JOHNSON is an Insider

ACHILLION PHARMACEUTICALS INC

Trading Symbol: ACHN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 22 2017
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aldeyra Therapeutics, Inc.

Trading Symbol: ALDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 1,750,292 shares
Current Value: $8,751,460
Latest Transaction: May 05 2014
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BARRIER THERAPEUTICS INC

Trading Symbol: BTRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 3,753,749 shares
Latest Transaction: Feb 15 2005

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CORNERSTONE THERAPEUTICS INC

Trading Symbol: CRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 2,104,704 shares
Latest Transaction: Jun 02 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Fusion Pharmaceuticals Inc.

Trading Symbol: FUSN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 2,945,516 shares
Latest Transaction: Jul 02 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOCEA BIOSCIENCES, INC.

Trading Symbol: GNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 1,388,645 shares
Current Value: $6,262,789
Latest Transaction: Feb 11 2014
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

IMMUNICON CORP

Trading Symbol: IMMC
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 1,771,571 shares
Latest Transaction: Jun 14 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Inspire Medical Systems, Inc.

Trading Symbol: INSP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 197,863 shares
Latest Transaction: May 07 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

JOHNSON & JOHNSON

Trading Symbol: JNJ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 2,945,516 shares
Current Value: $334,257,156
Latest Transaction: Jul 02 2020
$JNJ Market Capitalization: $308.51B
$JNJ Previous Close: $113.48

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Minerva Neurosciences, Inc.

Trading Symbol: NERV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 14 2017
$NERV Market Capitalization: $346.33M
$NERV Previous Close: $10.15

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Neoleukin Therapeutics, Inc.

Trading Symbol: NLTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 100,000 shares
Current Value: $1,881,000
Latest Transaction: Aug 12 2015
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NEVRO CORP

Trading Symbol: NVRO
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 2,066,740 shares
Current Value: $192,888,844
Latest Transaction: Jun 08 2015
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Protagonist Therapeutics, Inc

Trading Symbol: PTGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 965,517 shares
Current Value: $17,282,754
Latest Transaction: Aug 18 2016
$PTGX Market Capitalization: $282.80M
$PTGX Previous Close: $17.90

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Provention Bio, Inc.

Trading Symbol: PRVB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 2,400,000 shares
Latest Transaction: Jul 20 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TENGION INC

Trading Symbol: TNGN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHNSON & JOHNSON: 10% Owner
Holdings: 1,194,654 shares
Latest Transaction: Apr 14 2010

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of JOHNSON & JOHNSON

Sentiment: All, ACHN, ALDX, BTRX, CRTX, FUSN, GNCA, IMMC, INSP, JNJ, NERV, NLTX, NVRO, PTGX, PRVB, TNGN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerOption ExerciseC0.0089,118089,118
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerOption ExerciseC0.00475,80200
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerOption ExerciseC0.005,059,46000
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerOption ExerciseC0.0010,666,66700
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerBuyP17.00725,00012,325,0003,670,5162.9 M to 3.7 M (+24.61 %)
Jul 02 2020FUSNFusion Pharmaceuti ...JOHNSON & JOHNSON10% OwnerBuyC0.002,945,51602,945,5160 to 2.9 M
Jul 02 2020JNJJOHNSON & JOHNSONJOHNSON & JOHNSON10% OwnerOption ExerciseC0.0089,118089,118

View all JOHNSON & JOHNSON insider transactions.

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

Contact us | Follow us on Twitter